Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: A novel prothrombotic mechanism

Heart

Volumn 96, Issue 14, 2010, Pages 1114-1118

  Palka, Ilona ^a   Nessler, Jadwiga ^a   Nessler, Bohdan ^a   Piwowarska, Wiesława ^a   Tracz, Wieslawa ^b   Undas, Anetta ^b  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; STATIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBRIN CLOT; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HUMAN; MALE; PERMEABILITY; PLASMA; PRIORITY JOURNAL; SINUS RHYTHM; THROMBOCYTE; TURBIDITY;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; FIBRIN; FIBRINOLYSIS; HEART FAILURE; HEART RATE; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; THROMBOEMBOLISM;

EID: 77954449746     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.192740     Document Type: Article

References (29)

1. Sutton M, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981-8. (Pubitemid 30415891)
2. Mehta J, Mehta P. Platelet function studies in heart disease: enhanced platelet aggregate formation in congestive heart failure. Circulation 1979;60:497-503.
3. Davis CJ, Gurbel PA, Gattis WA, et al. Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge. Int J Cardiol 2000;75:15-21.
4. Cugno M, Mari D, Meroni PL, et al. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. Br J Haematol 2004;126:85-92.
5. Chung I, Lip GY. Platelets and heart failure. Eur Heart J 2006;27:2623-31.
6. Lip GYH, Lowe GDD, Runley A, et al. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin therapy. Br Heart J 1995;73:527-33.
7. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: 1. Clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
8. Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT studies. Circulation 1993;87:VI102-110.
9. Dunkman WB, Johnson GR, Carson PE, et al. Incidence of thromboembolic events in congestive heart failure. Circulation 1993;87:VI94-101.
10. Cioffi G, Pozzoli M, Forni G, et al. Systemic thromboembolism in chronic heart failure. a prospective study in 406 patients. Eur Heart J 1996;17:1381-9. (Pubitemid 26306667)
11. Freudenberger RS, Hellkamp AS, Halperin JL, et al. SCD-HeFT investigators. risk of thromboembolism in heart failure an analysis from the sudden cardiac death in heart failure trial (SCD-HeFT). Circulation 2007;115:2637-41.
12. Sharma ND, McCullough PA, Philbin EF, et al. Thromboembolism in patients with severe left systolic dysfunction. Chest 2000;117:314-20.
13. Shantsila E, Lip GY. The endothelium and thrombotic risk in heart failure. Thromb Haemost 2009;102:185-7.
14. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. analysis of the MEDENOX study. Arch Intern Med 2004;164:963-8.
15. Howell MD, Geracib JM, Knowlton AA. Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. J Clin Epidemiol 2001;54:810-16.
16. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005;3:1894-904.
17. Blombäck B, Carlsson K, Fatah K, et al. Fibrin in human plasma: gel architecture governed by rate and nature of fibrinogen activation. Thromb Res 1994;5:521-38.
18. Fatah K, Hamsten A, Blombäck B, et al. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost 1992;68:130-5.
19. Collet JP, Allali Y, Lesty C, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006;26:2567-73.
20. Undas A, Zawilska K, Ciesla-Dul M, et al. Altered fibrin clot structure/function as a novel risk factor for cryptogenic ischemic stroke. Stroke 2009;40:1499-501.
21. Undas A, Zawilska K, Ciesla-Dul M, et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 2009;114:4272-8.
22. Anon. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.
23. Undas A, Szuldrzynski K, Stepien E, et al. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effect of inflammation and oxidative stress. Atherosclerosis 2008;196:551-7.
24. Undas A, Celinska-Löwenhoff M, Löwenhoff T, et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary heart disease. J Thromb Haemost 2006;4:973-5.
25. Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004;24:1558-66.
26. Undas A, Topor-Madry R, Tracz W, et al. Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis. Thromb Haemost 2009;102:1289-91.
27. Benjamin EJ, D'Agostino RB, Belanger AJ, et al. Left atrial size and the risk of stroke and death. the framingham heart study. Circulation 1995;92:835-41.
28. Gibbs CR, Blann AD, Watson RDS, et al. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and ß-blocker therapy. Circulation 2001;103:1746-51.
29. Undas A, Zeglin M. Fibrin clot structure and cardiovascular disease. Vasc Dis Prev 2006;3:99-106.